Loading...
Deferring Nail Mycological Sampling during the COVID-19 Pandemic: Recommendations from a Multidisciplinary Panel of Nail Specialists
Lipner, Shari R. Ghannoum, Mahmoud Hinshaw, Molly A. Rich, Phoebe Ruben, Beth S. Scher, Richard K.
Lipner, Shari R.
Ghannoum, Mahmoud
Hinshaw, Molly A.
Rich, Phoebe
Ruben, Beth S.
Scher, Richard K.
Citations
Altmetric:
Genre
Journal article
Date
2021-12-08
Advisor
Committee member
Group
Department
Podiatric Medicine
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.1159/000520628
Abstract
Onychomycosis is the most common nail condition seen in clinical practice, with significant impact on quality of life. Clinical examination alone is insufficient for accurate diagnosis, but mycological confirmation can be challenging during the COVID-19 pandemic. In this letter, a multidisciplinary panel of dermatologists, a podiatrist, dermatopathologists, and a mycologist, discuss considerations for mycological sampling during the pandemic.
Description
Citation
Lipner SR, Ghannoum M, Hinshaw M, et al. Deferring Nail Mycological Sampling during the COVID-19 Pandemic: Recommendations from a Multidisciplinary Panel of Nail Specialists. Skin Appendage Disord. 2021. doi:10.1159/000520628
Citation to related work
Karger Publishers
Has part
Skin Appendange Disorders
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu